BioWorld® - Medical Device Daily

Ceres Inc.
BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
1535 Rancho Conejo Blvd.
Thousand Oaks CA 91320, US
Phone: (805) 376-6500
Web: www.ceres.net
E-mail: info@ceresbiotechnology.com
KEY PERSONNEL: Walter De Logi; Chairman
Dr. Richard Hamilton; CEO
Dr. Patrick McCroskey; CFO
Dr. Richard Flavell; CSO
Dr. Anne-Marie Bouckaert; Sr. VP, Technology Planning, Protection and
Acquisition
Ms. Wilfriede van Assche; Sr. VP, General Counsel and Secretary
Dr. Kenneth Feldmann; VP, Agricultural Genomics/Trait Development
Dr. Peter Mascia; VP, Product Development
Dr. Steven Bobzin; Director, Natural Products Chemistry
Dr. Roger Pennell; Director, Trait Development
Anna Rath; Director, Business Development
Dr. Steven Thomas; Director, Bioproducts
EMPLOYEES: 135 employees
HISTORY: Founded in 1997
STOCK-FINANCIAL HISTORY: Privately held
PRINCIPAL INVESTORS: Ambergate Trust
Artal Luxembourg SA
GIMV NV
Hambrecht & Quist Capital
KBC Bank & Insurance Group
Monsanto Co.
Oppenheimer International Growth Fund
Oxford Bioscience Partners
QuestMark Partners LP
Soros Private Equity Partners
BUSINESS STRATEGY: Develop energy crops such as switchgrass, miscanthus and poplar for
cellulosic ethanol
Leverage its technologies into established markets through strategic
partnerships
AGREEMENTS: Name Products Content of Agreement Date
Agricultural improvement of
CRADA 2/06
Research Service switchgrass genetics
(ARS) at the
United States
Department of
Agriculture
through biotechnology
Aurora
Aurora's fluorescent licensing
10/00
Biosciences Corp. protein technology for
use in agricultural
applications
agreement
Genset agricultural genetics alliance 1/98
Monsanto Co. application of genomics discovery and 4/02
technologies to provide development
improvements in certain
agricultural crops
collaboration
Oregon State use of genomics to collaboration 9/05
University
enhance biomassmediated
carbon
sequestration
agreement
Copyright ©2006 AHC Media ® 112